Hulda R Jonsdottir

8PUBLICATIONS
19CO-AUTHORS
Gene and molecular therapyEpidemiological methodsInnate immunityMedical biotechnology diagnostics (incl. biosensors)Natural products and bioactive compounds
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 26, 2024
Multidrug Combinations against SARS-CoV-2 Using GS-441524 or Ivermectin with Molnupiravir and/or Nirmatrelvir in Reconstituted Human Nasal Airway Epithelia.

Denise Siegrist, Hulda R Jonsdottir, Mendy Bouveret

|Sep 28, 2024
Immune Response after Vaccination against Tick-Borne Encephalitis Virus (TBEV) in Horses.

Dana Kälin, Angela Becsek, Helen Stürmer

|Jul 23, 2022
Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies.

Ozge Ardicli, K Tayfun Carli, Pattraporn Satitsuksanoa

|Jan 05, 2022
Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.

Michael P Horn, Hulda R Jonsdottir, Daniel Brigger

|Mar 06, 2021
Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults.

Hulda R Jonsdottir, Michel Bielecki, Denise Siegrist

|Sep 10, 2020
In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.

Johanna Signer, Hulda R Jonsdottir, Werner C Albrich

Pageof 2

Frequent Collaborators

3 joint publications

Alexander Eggel

1 joint publications

Dirk Geerts

1 joint publications

Volker Thiel

1 joint publications

Ronald Dijkman